Mercury Biopharmaceutical Corporation (TPEX:6932)

Mercury Biopharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	67.32	68.01	44.29	31.94	2.56	0.09
Short-Term Investments	131.6	162.8	284.78	108.7	-	-
Cash & Short-Term Investments	198.92	230.81	329.07	140.64	2.56	0.09
Cash Growth	-24.91%	-29.86%	133.99%	5391.45%	2877.91%	-43.79%
Other Receivables	0.45	0.53	0.23	2.46	-	-
Receivables	0.45	0.53	0.23	2.46	-	-
Prepaid Expenses	8.89	11.38	10.07	2.64	-	0.01
Other Current Assets	0.35	0.18	0.55	-	1.37	-
Total Current Assets	208.6	242.9	339.93	145.73	3.93	0.1
Property, Plant & Equipment	93.14	94.41	79.94	75.15	8.46	-
Other Intangible Assets	5.24	4.53	2.71	0.5	0.49	-
Other Long-Term Assets	10.04	11.37	15.5	8.55	0.51	-
Total Assets	317.02	353.2	438.08	229.93	13.38	0.1
Accrued Expenses	-	-	-	4.61	0.66	0.01
Short-Term Debt	-	-	-	-	-	0.3
Current Portion of Long-Term Debt	2.1	1.21	-	-	-	-
Current Portion of Leases	2.72	2.6	0.68	1.05	0.79	-
Current Unearned Revenue	5.79	5.48	0.44	-	-	-
Other Current Liabilities	12.04	9.94	6.93	1.57	0.26	-
Total Current Liabilities	22.64	19.24	8.05	7.23	1.7	0.31
Long-Term Debt	39.16	40.39	41.6	41.6	-	-
Long-Term Leases	2.88	3.31	0.07	0.77	1.22	-
Total Liabilities	64.68	62.93	49.72	49.6	2.93	0.31
Common Stock	105.5	105.46	103.99	100.87	15.4	0.2
Additional Paid-In Capital	241.04	291.29	328.17	110.72	0.37	-
Retained Earnings	-38.33	-50.57	-43.82	-31.25	-5.31	-0.41
Treasury Stock	-56.24	-56.24	-	-	-	-
Comprehensive Income & Other	0.38	0.33	0.01	-	-	-
Shareholders' Equity	252.34	290.27	388.35	180.33	10.46	-0.21
Total Liabilities & Equity	317.02	353.2	438.08	229.93	13.38	0.1
Total Debt	46.85	47.51	42.35	43.42	2.01	0.3
Net Cash (Debt)	152.06	183.3	286.73	97.21	0.55	-0.21
Net Cash Growth	-31.79%	-36.07%	194.94%	17575.09%	-	-
Net Cash Per Share	0.37	0.43	0.72	0.26	0.00	-0.00
Filing Date Shares Outstanding	425.86	421.85	415.96	403.46	403.46	104
Total Common Shares Outstanding	425.86	421.85	415.96	403.46	307.94	104
Working Capital	185.96	223.66	331.88	138.5	2.22	-0.21
Book Value Per Share	0.59	0.69	0.93	0.45	0.03	-0.00
Tangible Book Value	247.1	285.75	385.65	179.83	9.97	-0.21
Tangible Book Value Per Share	0.58	0.68	0.93	0.45	0.03	-0.00
Land	-	-	-	41.9	-	-
Buildings	-	-	-	18.12	-	-
Machinery	-	-	-	6.42	5.88	-
Construction In Progress	-	-	-	7.5	-	-
Leasehold Improvements	-	-	-	0.91	0.91	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.